[breadcrumb_custom]

Let’s Start With The Stock Forecast For Emergent Biosolutions Inc (NYSE: EBS)

In the last trading session, 2.05 million Emergent Biosolutions Inc (NYSE:EBS) shares changed hands as the company’s beta touched 0.98. With the company’s per share price at $1.58 changed hands at -$0.1 or -5.95% during last session, the market valuation stood at $81.97M. EBS’s last price was a discount, traded about -954.43% off its 52-week high of $16.66. The share price had its 52-week low at $1.42, which suggests the last value was 10.13% up since then. When we look at Emergent Biosolutions Inc’s average trading volume, we note the 10-day average is 1.35 million shares, with the 3-month average coming to 1.53.

Emergent Biosolutions Inc (NYSE:EBS) trade information

Instantly EBS was in red as seen at the end of in last trading. With action -2.47%, the performance over the past five days has been red. The drop to weekly highs of 1.6800 subtracted -5.95% to the stock’s daily price. The company’s shares are showing year-to-date downside of -34.17%, with the 5-day performance at -2.47% in the red. However, in the 30-day time frame, Emergent Biosolutions Inc (NYSE:EBS) is -27.19% down. Looking at the short shares, we see there were 10.44 million shares sold at short interest cover period of 8.81 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Emergent Biosolutions Inc (EBS) estimates and forecasts

Data shows that the Emergent Biosolutions Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -72.38% over the past 6 months, a -77.58% in annual growth rate that is considerably lower than the industry average of 15.50%.

Emergent Biosolutions Inc (NYSE:EBS)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.52% of Emergent Biosolutions Inc shares while 80.34% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 82.42%. There are 80.34% institutions holding the Emergent Biosolutions Inc stock share, with Blackrock Inc. the top institutional holder. As of Jun 29, 2023, the company held 17.82% of the shares, roughly 9.23 million EBS shares worth $67.85 million.

State Street Corporation holds the second largest percentage of outstanding shares, with 13.11% or 6.79 million shares worth $49.94 million as of Jun 29, 2023.

Among Mutual Funds, the top two as of Aug 30, 2023 were SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. With 4.9 million shares estimated at $22.99 million under it, the former controlled 9.46% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.79% of the shares, roughly 1.44 million shares worth around $10.61 million.

On Key

Related Posts